fda glp-1 news november 2025 glp-1 shortage news november 2025 The FDA has removed semaglutide injection products (GLP-1) from Wegovy pill: With FDA approval,

Learn why this happens and what you can do

There are several Phase 3 trials evaluating GLP-1s for conditions, such as prediabetes, Alzheimer's disease, diabetic retinopathy and osteoarthritis of the knee (in patients with obesity)

Of these 102 liraglutide injection-treated patients, 56 (5%) patients developed antibodies that cross-reacted with native GLP-1

Weight In addition to helping regulate blood sugar, semaglutide has been shown to help people lose significant amounts of weight by reducing caloric intake

A licensed healthcare provider reviews your medical intake form and determines eligibility

The rate of deamidation roughly doubles for every 10 degrees Celsius increase in temperature